Mesa Laboratories Inc (MLAB) stock
MLABNasdaqIndustrial Instruments For Measurement, Display, and ControlFiscal year ends March 31
Financials through Q2 FY2027, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 9, 2026Score 11/3074% above fair value
$139.01+3.81 (+2.82%)
Close on Nov 13, 2026Market cap $777.88MP/E 120.9Yield 0.46%
Mesa Laboratories r&d expenses
Research and development expenses are spending on new products and technology.
Mesa Laboratories's R&D Expenses for the twelve months ending Sep 30, 2026 was $20.05M, down 0.6% year over year. For fiscal 2026 it was $20.31M, up 4.0% from the year before. Over ten years it grew 17.7% a year on average. The highest annual figure on record is $20.49M in fiscal 2023.
Annual r&d expenses
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2026 | Mar 31, 2026 | $20.31M | +4.0% |
| FY2025 | Mar 31, 2025 | $19.52M | +1.1% |
| FY2024 | Mar 31, 2024 | $19.30M | -5.8% |
| FY2023 | Mar 31, 2023 | $20.49M | +30.0% |
| FY2022 | Mar 31, 2022 | $15.77M | +51.8% |
| FY2021 | Mar 31, 2021 | $10.39M | +63.5% |
| FY2020 | Mar 31, 2020 | $6.36M | +81.3% |
| FY2019 | Mar 31, 2019 | $3.51M | -0.9% |
| FY2018 | Mar 31, 2018 | $3.54M | -14.9% |
| FY2017 | Mar 31, 2017 | $4.16M | +4.7% |
| FY2016 | Mar 31, 2016 | $3.97M | +20.6% |
| FY2015 | Mar 31, 2015 | $3.29M | +42.0% |
| FY2014 | Mar 31, 2014 | $2.32M | +15.4% |
| FY2013 | Mar 31, 2013 | $2.01M | +48.0% |
| FY2012 | Mar 31, 2012 | $1.36M | -5.7% |
| FY2011 | Mar 31, 2011 | $1.44M | – |
Quarterly r&d expenses
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2027CQ3 2026 | Sep 30, 2026 | $5.05M | +0.1% |
| Q1 FY2027CQ2 2026 | Jun 30, 2026 | $4.73M | -5.2% |
| Q4 FY2026CQ1 2026 | Mar 31, 2026 | $5.25M | +3.0% |
| Q3 FY2026CQ4 2025 | Dec 31, 2025 | $5.03M | -0.5% |
| Q2 FY2026CQ3 2025 | Sep 30, 2025 | $5.05M | +8.9% |
| Q1 FY2026CQ2 2025 | Jun 30, 2025 | $4.98M | +5.3% |
| Q4 FY2025CQ1 2025 | Mar 31, 2025 | $5.10M | -2.0% |
| Q3 FY2025CQ4 2024 | Dec 31, 2024 | $5.05M | +17.7% |
| Q2 FY2025CQ3 2024 | Sep 30, 2024 | $4.63M | -7.2% |
| Q1 FY2025CQ2 2024 | Jun 30, 2024 | $4.74M | -1.6% |
| Q4 FY2024CQ1 2024 | Mar 31, 2024 | $5.20M | +4.0% |
| Q3 FY2024CQ4 2023 | Dec 31, 2023 | $4.29M | -10.5% |
| Q2 FY2024CQ3 2023 | Sep 30, 2023 | $4.99M | +0.1% |
| Q1 FY2024CQ2 2023 | Jun 30, 2023 | $4.81M | -15.6% |
| Q4 FY2023CQ1 2023 | Mar 31, 2023 | $5.00M | -3.4% |
| Q3 FY2023CQ4 2022 | Dec 31, 2022 | $4.80M | -7.1% |
| Q2 FY2023CQ3 2022 | Sep 30, 2022 | $4.99M | +90.9% |
| Q1 FY2023CQ2 2022 | Jun 30, 2022 | $5.70M | +102.8% |
| Q4 FY2022CQ1 2022 | Mar 31, 2022 | $5.18M | +93.8% |
| Q3 FY2022CQ4 2021 | Dec 31, 2021 | $5.16M | +90.9% |
| Q2 FY2022CQ3 2021 | Sep 30, 2021 | $2.61M | +8.2% |
| Q1 FY2022CQ2 2021 | Jun 30, 2021 | $2.81M | +8.3% |
| Q4 FY2021CQ1 2021 | Mar 31, 2021 | $2.67M | +15.7% |
| Q3 FY2021CQ4 2020 | Dec 31, 2020 | $2.71M | +28.2% |
| Q2 FY2021CQ3 2020 | Sep 30, 2020 | $2.41M | +163.8% |
| Q1 FY2021CQ2 2020 | Jun 30, 2020 | $2.60M | +154.8% |
| Q4 FY2020CQ1 2020 | Mar 31, 2020 | $2.31M | +139.0% |
| Q3 FY2020CQ4 2019 | Dec 31, 2019 | $2.11M | +145.3% |
| Q2 FY2020CQ3 2019 | Sep 30, 2019 | $915.00K | +8.7% |
| Q1 FY2020CQ2 2019 | Jun 30, 2019 | $1.02M | +21.7% |
| Q4 FY2019CQ1 2019 | Mar 31, 2019 | $967.00K | +29.1% |
| Q3 FY2019CQ4 2018 | Dec 31, 2018 | $860.00K | +14.4% |
| Q2 FY2019CQ3 2018 | Sep 30, 2018 | $842.00K | -4.9% |
| Q1 FY2019CQ2 2018 | Jun 30, 2018 | $837.00K | -27.4% |
| Q4 FY2018CQ1 2018 | Mar 31, 2018 | $749.00K | -38.4% |
| Q3 FY2018CQ4 2017 | Dec 31, 2017 | $752.00K | -12.7% |
| Q2 FY2018CQ3 2017 | Sep 30, 2017 | $885.00K | – |
| Q1 FY2018CQ2 2017 | Jun 30, 2017 | $1.15M | – |
| Q4 FY2017CQ1 2017 | Mar 31, 2017 | $1.22M | – |
| Q3 FY2017CQ4 2016 | Dec 31, 2016 | $861.00K | – |
See a number that looks wrong?